A Phase 2 Study of E6011 in Subjects With Rheumatoid Arthritis Inadequately Responding to Biologics

Eisai Trial Site #1, Yotsukaidō

Eisai Trial Site #1, Matsuyama

Eisai Trial Site #1, Kitakyushu

Eisai Trial Site #1, Takasaki

Eisai Trial Site #2, Takasaki

Eisai Trial Site #1, Asahikawa

Eisai Trial Site #1, Sapporo

Eisai Trial Site #2, Sapporo

Eisai Trial Site #3, Sapporo

Eisai Trial Site #1, Katō

Eisai Trial Site #1, Ono

Eisai Trial Site #1, Tsukuba

Eisai Trial Site #1, Sagamihara

Eisai Trial Site #1, Yokohama

Eisai Trial Site #1, Sasebo

Eisai Trial Site #1, Tomigusuku

Eisai Trial Site #1, Kawachi-Nagano

Eisai Trial Site #1, Kawagoe

Eisai Trial Site #1, Kawaguchi

Eisai Trial Site #1, Tokorozawa

Eisai Trial Site #1, Hamamatsu

Eisai Trial Site #1, Shimotsuke

Eisai Trial Site #1, Chūō

Eisai Trial Site #1, Fuchū

Eisai Trial Site #1, Meguro-ku

Eisai Trial Site #1, Ōta-ku

Eisai Trial Site #1, Setagaya City

Eisai Trial Site #1, Shinjuku

Eisai Trial Site #2, Shinjuku

Eisai Trial Site #1, Takaoka

Eisai Trial Site #1, Chiba

Eisai Trial Site #1, Fukui

Eisai Trial Site #2, Fukuoka

Eisai Trial Site #3, Fukuoka

Eisai Trial Site #4, Fukuoka

Eisai Trial Site #5, Fukuoka

Eisai Trial Site #1, Hiroshima

Eisai Trial Site #1, Kagoshima

Eisai Trial Site #1, Kochi

Eisai Trial Site #1, Kyoto

Eisai Trial Site #1, Nagasaki

Eisai Trial Site #2, Nagasaki

Eisai Trial Site #3, Nagasaki

Eisai Trial Site #1, Ōita

Eisai Trial Site #1, Toyama